Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 26,877 | 26,071 | 22,343 | 23,581 | 20,882 |
| Operating Income | -26,877 | -26,071 | -22,343 | -23,581 | -20,882 |
| Other Income | 362 | 217 | 194 | 204 | 198 |
| Pre-tax Income | -26,515 | -25,854 | -22,149 | -23,377 | -20,684 |
| Net Income Continuous | -26,515 | -25,854 | -22,149 | -23,377 | -20,684 |
| Net Income | $-26,515 | $-25,854 | $-22,149 | $-23,377 | $-20,684 |
| EPS Basic Total Ops | -0.31 | -0.36 | -0.35 | -0.37 | -0.33 |
| EPS Basic Continuous Ops | -0.31 | -0.36 | -0.35 | -0.37 | -0.33 |
| EPS Diluted Total Ops | -0.31 | -0.36 | -0.35 | -0.37 | -0.33 |
| EPS Diluted Continuous Ops | -0.31 | -0.36 | -0.35 | -0.37 | -0.33 |
| EBITDA(a) | $-26,649 | $-25,829 | $-22,115 | $-23,329 | $-20,633 |